Published • loading... • Updated
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit
- Rosen Law Firm advises purchasers of Erasca, Inc. common stock from January 14, 2025, to April 26, 2026, about an August 10, 2026, deadline to lead a securities fraud lawsuit.
- Purchasers of Erasca common stock during this period may receive compensation without upfront fees through a contingency fee arrangement.
- The lawsuit alleges that Erasca, Inc., its CEO, and CFO made false statements about their oncology drug ERAS-0015 and improperly compared it to a competitor's drug.
- When the true facts were revealed, investors suffered financial losses according to the lawsuit.
Insights by Ground AI
39 Articles
39 Articles
SES Investors Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit with the ...
LOS ANGELES, June 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SES AI Corporation (“SES” or “the Company”) (NYSE: SES ) for violations of §§10(b)…
Coverage Details
Total News Sources39
Leaning Left7Leaning Right3Center12Last UpdatedBias Distribution54% Center
Bias Distribution
- 54% of the sources are Center
54% Center
L 32%
C 54%
14%
Factuality
To view factuality data please Upgrade to Premium
